Indeed, higher circulating AMH levels has been correlated with the reduced inflammation marker C-reactive protein in men.180 Disturbed inflammatory responses have been proposed as an additional driver of PAH development,181 therefore, reducing inflammation via increased AMH signalling in BMPR2 mutant carriers might be beneficial in PAH. Here, BMPR2 is linked to pulmonary arterial hypertension.